Surrey Heartlands

Joint Formulary & PAD

Mistletoe extract - Palliative care

You are here : Home > Formulary Search > Mistletoe extract - Palliative care

I agree that in using this database I understand that this platform only provides guidance on local prescribing policy and that all prescribing decisions are ultimately the responsibility of the clinician.

Status 1

See narrative
Formulations :
  • Not Specified
Formulary Status :
Primary Care
ASPH
RSFT
SASH
SABP
Associated Icons :
Guidelines SPC
Restrictions / Comments :

Documentation

Policy Statement
Mistletoe extract for the treatment of cancer or palliative care - Policy statement PCN 359-2018 - September 2018.pdf
Evidence Review
Iscador (Mistletoe extract) for cancer or palliative care - Evidence review - Jul 2013
Information
Mistletoe extract - Q & As UKMI - October 2017.pdf

PAD Profile

ChemicalSubstance :
Mistletoe extract
Indication :
Palliative care
Group Name :
Keywords :
mistletoe extract; semi-parasitic plant
Brand Names Include :
Iscador, Eurixor, Lektinol, cefalektin, AbnobaVISCUM, Helixor,Isorel, Iscucin
Important Information :
Latest Additions Date From :
Latest Additions Date To :
Guidelines :
Palliative care
Supporting Documents :
3

Other Indications

Below are listed other indications that Mistletoe extract is used to treat.

Other Drugs

Below are listed other drugs that are used to treat Palliative care.

  • No records returned.

Committee Recommendations (2)

03 Jun 20 - Surrey & North West Sussex Area Prescribing Committee (formerly Prescribing Clinical Network)

At the Surrey and North-West Sussex Area Prescribing Committee (APC) held in June 2020, it was decided that all BLACK status drugs would have their review dates extended for 5 years without the need for a review.

If a clinician or provider wishes to change the traffic light status of any BLACK drug then they will need to submit a paper for change as per usual APC process.

05 Sep 18 - Surrey & North West Sussex Area Prescribing Committee (formerly Prescribing Clinical Network)

The PCN does not support the routine use of mistletoe extract for the treatment of cancer or palliative care.
Mistletoe extract will be considered as BLACK on the traffic light system